People channel feed

The Bell Labs of biotech: Stu­art Schreiber has bil­lion­aire sup­port for new bio­med­ical in­sti­tute 

Last year
Startups

Ver­tex founder Joshua Boger on sur­viv­ing down­turns, 'painful' part­ner­ships, and the im­por­tance of cul­ture: #JPM24

Last year
Startups

Ex-Cel­gene chief Mark Alles, for­mer Goldfinch Bio leader Tony John­son are back in the game as CEOs

Last year
Peer Review

C4 Ther­a­peu­tics cuts staff, re­struc­tures to fo­cus on lead pro­tein degra­da­tion pro­grams, dis­cov­ery pacts

Last year
R&D

El­liot­t's Marc Stein­berg sees more health­care in­vest­ments for the some­times-ac­tivist firm this year: #JPM24

Last year
Financing

Ex­elix­is cuts 175 staffers to pri­or­i­tize late-stage drug de­vel­op­ment   

Last year
R&D

Af­fimed cuts up to 50% of em­ploy­ees to sup­port clin­i­cal projects, CEO de­parts

Last year
R&D

AlloVir lays off 95% of staffers af­ter shut­ter­ing PhI­II an­tivi­ral cell ther­a­py tri­als 

Last year
R&D

Evotec CEO Wern­er Lan­thaler re­signs; Af­ter No­vo deal, ex-For­ma chief ush­ers in new era at Paci­ra

Last year
Peer Review

In­tel­lia Ther­a­peu­tics cuts 15% of work­force, ex­tends cash run­way in­to mid-2026

Last year
R&D

Feng Zhang's CRISPR start­up Aera shrinks head­count by a quar­ter

Last year
Startups

Up­dat­ed: Delfi Di­ag­nos­tics hires Il­lu­mi­na’s chief com­mer­cial of­fi­cer as next CEO

Last year
Diagnostics

Ther­mo Fish­er to shut­ter Petaluma man­u­fac­tur­ing fa­cil­i­ty, lay off 74 staffers by Feb­ru­ary

Last year
Manufacturing

Scoop: Re­silience re­ceives Form 483 due to mold at Cana­di­an site, more lay­offs an­tic­i­pat­ed

Last year
FDA+
Manufacturing

Ex­clu­sive: Roger Perl­mut­ter on the biggest prob­lem in Big Phar­ma, leav­ing Mer­ck, and build­ing Eikon

Last year
Startups
R&D

Bio­Marin strikes co­op­er­a­tion deal with ac­tivist in­vestor El­liott, sets up re­view com­mit­tee and adds board mem­bers

Last year
Pharma

Scoop: Re­silience down­sizes tech­ni­cal R&D and qual­i­ty as­sur­ance di­vi­sions

Last year
Manufacturing

Aclaris halves head­count, banks on next mid-stage read­out af­ter clin­i­cal set­backs tanked shares

Last year

Ver­i­ly’s chief med­ical of­fi­cer Amy Aber­nethy is step­ping down

Last year
Health Tech

Q&A: JP Mor­gan’s new life sci­ences pri­vate cap­i­tal leader on the bank’s ex­pand­ing am­bi­tions, vet­ting star­tups and Abu Dhabi’s biotech push

Last year
Financing

Pub­li­cis Health names new chief ex­ec­u­tive from its agency net­work

Last year
Marketing

Jay Brad­ner joins Am­gen to lead R&D as David Reese moves to new chief tech­nol­o­gy of­fi­cer role

Last year
R&D

Ex­clu­sive: Renowned im­munol­o­gy leader 'Skip' Vir­gin is out as Al­tos Labs med­ical chief

Last year

Vir down­sizes by 12%, will close St. Louis and Port­land sites in 2024 to save $40M+ an­nu­al­ly

Last year
First page Previous page 15161718192021 Next page Last page
A service from the Financial Times